
"Good" sales meetings don't mean a deal
40–60% of qualified B2B opportunities end in no decision. Engagement doesn't equal commitment — here's what actually moves deals forward.
The meeting went well. The prospect was engaged, asked good questions, and said they’d be in touch. Then nothing. Two weeks pass. A follow-up email gets a polite non-answer. The deal quietly dies without ever producing an explicit rejection.
This pattern is one of the most common — and most costly — in complex B2B sales. Research consistently shows that 40–60% of qualified opportunities end in “no decision” rather than a loss to a competitor. Sellers mistake engagement for commitment, and positive meetings for deal momentum. They’re not the same thing.
Why buyers go quiet
The obstacles that prevent decisions from being made rarely surface in the meeting itself. Buyers are polite. They engage with the demo, they nod at the ROI numbers, they say “this looks really interesting.” But back in their organisation, the real barriers emerge:
- Choice paralysis — too many options with no clear basis for comparison
- Confidence gaps — insufficient conviction to justify the investment internally
- Implementation risk — fear of disruption with no clear adoption path
- Unknown stakeholders — decision-makers whose concerns were never addressed
- Vague next steps — follow-ups that mask a stalled process
A post-meeting diagnostic
After any meaningful meeting, run through four questions before you write your follow-up:
- Can the buyer internally justify this purchase in their own words?
- Were the major objections surfaced and genuinely resolved — not just acknowledged?
- Have all decision-makers been identified, including the ones you haven’t met yet?
- Do the agreed next steps include a specific date, specific attendees, and a specific outcome?
If the answer to any of those is no — or uncertain — then the meeting didn’t move the deal as far as it felt like it did. The goal of every meeting is to reduce uncertainty, not just create activity. A warm interaction with unresolved ambiguity is a pleasant delay, not progress.
Specificity as a forcing function
The best indicator of deal health isn’t how enthusiastic the buyer seemed — it’s how specific the next steps are. “Let’s chat next week” is not a next step. “A 30-minute call on Tuesday at 2pm with you, your CTO, and your head of RevOps to walk through the integration questions” is a next step.
Specificity forces clarity. It surfaces hesitation that politeness would otherwise conceal. And it separates the deals that are genuinely moving from the ones that just feel like they are.